FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

44 letters match. Newest first.

  1. Nexus Health Solutions LLC dba Harper Meds

    FDA warned telehealth seller Harper Meds that its website misbrands compounded semaglutide and tirzepatide with false and misleading claims.

    Low
  2. Trinity HealthCare Supply, LLC dba altRx

    FDA warns altRx over misleading website claims for compounded semaglutide and tirzepatide, including 'clinically proven' and wrong compounder label.

    Low
  3. VivioMD Group LLC dba VivioMD

    FDA warned VivioMD that its website misbrands compounded semaglutide and tirzepatide by implying VivioMD is the compounder.

    Low
  4. Nexlife Inc. dba Nexlife

    FDA warned Nexlife that its website labels for compounded semaglutide and tirzepatide falsely suggest Nexlife is the compounder.

    Low
  5. Ezra Holdco LLC dba Ezra

    FDA says Ezra's website misbrands compounded semaglutide and tirzepatide by labeling them as Ezra-made when they are not.

    Low
  6. FITISH

    FDA warned FITISH over misleading website claims for compounded semaglutide and tirzepatide, including labels suggesting it is the compounder.

    Low
  7. Roen Health, Inc. dba RoenRx

    FDA warned RoenRx that its website misbrands compounded semaglutide with misleading approval claims and a company label implying it makes the drug.

    Medium
  8. Joi and Blokes dba Joi + Blokes

    FDA warned telehealth seller Joi + Blokes that its website misbrands compounded semaglutide and tirzepatide with false, misleading claims.

    Medium
  9. Clover Meds LLC dba Clover Meds

    Clover Meds, a telehealth seller, misbranded compounded semaglutide and tirzepatide with false website claims that it makes the drugs and uses 'FDA-licensed' facilities.

    Medium
  10. PolleyMed, LLC

    FDA says PolleyMed's SaniiSwab nasal swab is an unapproved, misbranded drug sold online with infection-prevention claims and a false FDA approval claim.

    High risk
  11. Weightless Medical LLC dba WeightCare

    FDA warned telehealth seller WeightCare that its website falsely presents it as the compounder of semaglutide and tirzepatide drugs.

    Low
  12. Viv Health, Inc. dba VIV RX

    FDA warned telehealth company VIV RX that its website falsely suggests it compounds semaglutide and tirzepatide, making the drugs misbranded.

    Medium
  13. Good Girl LLC dba GoodGirlRX

    FDA warns telehealth seller GoodGirlRX that its website misbrands compounded semaglutide and tirzepatide, claiming FDA approval and implying it is the compounder.

    Medium
  14. Ivim Services LLC dba Ivim

    FDA says Ivim's telehealth website mislabels compounded semaglutide and tirzepatide as Ivim-made when it is not the compounder.

    Low
  15. Join Josie

    FDA says Join Josie's website misbranded compounded semaglutide and tirzepatide by falsely implying FDA approval and naming Join Josie as compounder.

    Low
  16. Kin Meds

    FDA warned Kin Meds over false claims for compounded semaglutide and tirzepatide, including implying it is the compounder and that products are approved.

    Low
  17. Levity Inc. dba Levity

    FDA warned Levity over misleading website claims for compounded semaglutide and liraglutide, including implying Levity made the drugs and that they were FDA-approved.

    Low
  18. Better Health Labs, Inc. dba Measured

    FDA warned telehealth seller Measured its website misbranded compounded semaglutide and tirzepatide by implying it made them and that they were FDA-approved.

    Medium
  19. Dripgym Mobile Parent, LLC dba Amp Health

    FDA warned Amp Health that its website misbranded compounded semaglutide and tirzepatide with false maker and approval-implying claims.

    Low
  20. Belle Health LLC dba Belle

    FDA warned Belle Health that its website falsely suggests Belle compounds semaglutide and tirzepatide, making the drugs misbranded.

    Low
  21. Aspen Aesthetics dba Fifty 410

    FDA warns Fifty 410 over misleading website claims for compounded semaglutide and tirzepatide, including implied compounding and 'clinically proven' claims.

    Low
  22. Genesis Health International Inc. dba Genesis

    FDA warns Genesis over misleading website claims for compounded semaglutide and tirzepatide.

    Low
  23. Healthy Living Clinic

    FDA warned Healthy Living Clinic that its website misbrands compounded semaglutide by comparing it to Wegovy, Ozempic, and Rybelsus.

    Low
  24. Lovely Meds, Inc. dba Lovely Meds

    FDA cited Lovely Meds for misleading website claims that compounded semaglutide and tirzepatide are the same as FDA-approved drugs.

    Low
  25. Hello Cake, Inc. dba Hello Cake

    FDA warns Hello Cake, an online telehealth seller, that its website misbrands compounded sildenafil and tadalafil ED drugs as equivalent to Viagra and Cialis.

    Medium
  26. Bioverse, Inc. dba Bioverse

    FDA warned Bioverse that its website made false or misleading claims for compounded semaglutide and tirzepatide drugs.

    Low
  27. Fancy Meds, LLC dba Fancy Meds

    FDA warns Fancy Meds that its compounded semaglutide and tirzepatide website claims are false or misleading.

    Low
  28. SeniorLife Technologies, Inc.

    FDA warns SeniorLife Technologies that its SeniorLife.AI app is unapproved and misbranded, with quality-system and reporting failures.

    High risk
  29. XO Biologix, LLC

    XO Biologix markets MaviX, an amniotic-fluid product, as an unapproved new drug and unlicensed biologic.

    High risk
  30. EnviroServe Chemicals & Cleaners Ltd.

    EnviroServe's SOPURE hand sanitizer had manufacturing-quality violations and was sold as an unapproved, misleadingly labeled drug.

    High risk
  31. Aqualex Co., Ltd.

    Aqualex, a Korean contract manufacturer, was cited for manufacturing failures and an unapproved OTC sunscreen with misleading labeling.

    High risk
  32. Vitang Technology LLC

    Vitang Technology sold dental aligners designed with uncleared software without a new 510(k) and with quality system failures.

    High risk
  33. Varigard, LLC

    Varigard sold hand sanitizers with unapproved COVID-19 claims as unapproved new drugs, FDA says.

    High risk
  34. Databazaar.com

    Databazaar.com sells KN95 masks claiming COVID-19 protection without FDA approval or clearance.

    High risk
  35. Pairon Solutions LLC

    Pairon Solutions sold KN95, surgical, and 3-ply face masks without FDA clearance and with misleading FDA certification claims.

    Medium
  36. Secret of the Islands

    FDA warned Secret of the Islands that its salt scrub products are unapproved and misbranded drugs because of COVID-19 claims.

    High risk
  37. Captain's Cloth LLC

    FDA warned Captain's Cloth that it sold unapproved KN95 face masks online with misleading FDA-logo claims.

    Medium
  38. World Packaging Solutions, LLC

    FDA warned World Packaging Solutions over selling unapproved Purvigor KN95 masks with misleading FDA approval claims.

    High risk
  39. Nature’s Distributing; Club Clean Inc/BuyMedicalMasksNow.com

    FDA warned Nature’s Distributing/Club Clean for selling unapproved KN95 and 3-ply masks with false FDA certification claims for COVID-19.

    High risk
  40. BMHshop

    BMHshop sold unapproved KN95 and surgical masks with COVID-19 claims and misleading FDA registration certificates, FDA warned.

    High risk
  41. maskshell.com

    FDA warned maskshell.com over selling unapproved, misbranded KN95, surgical, and children’s masks with misleading FDA-logo certifications.

    High risk
  42. Innova Medical Group, Inc.

    Innova Medical Group distributed unapproved COVID-19 antigen tests and had quality-system and labeling violations, FDA says.

    High risk
  43. Ikcon Investments, Inc dba Ikcon Medical

    FDA warned Ikcon Medical that it sold unapproved COVID-19 antibody and antigen tests online and made misleading 'FDA registered' claims.

    High risk
  44. SafaLab, Inc.

    FDA and FTC warned SafaLab over unapproved, misbranded COVID-19 drug claims for The Prevention 12 Pak supplements.

    High risk